A new prognostic model for predicting overall survival and progression-free survival in unresectable hepatocellular carcinoma treated with the FOLFOX-HAIC regimen based on patient clinical characteristics and blood biomarkers

A new prognostic model for predicting overall survival and progression-free survival in unresectable hepatocellular carcinoma treated with the FOLFOX-HAIC regimen based on patient clinical characteristics and blood biomarkers

Abstract Background We developed a prognostic model to evaluate the overall survival (OS) and progression-free survival (PFS) of patients with unresectable hepatocellular carcinoma (u-HCC) treated with Hepatic arterial infusion chemotherapy of infusion oxaliplatin, fluorouracil and leucovorin (FOLFO...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiuyao Zeng, Zehong Zhou, Ji Zhang, Rongzeng Cai, Hongwei Yang, Pengfei Chen, Linfang Li
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Unresectable hepatocellular carcinoma
Hepatic arterial infusion chemotherapy
Prognostic model
Lasso regression
Nomogram
Online Access:https://doi.org/10.1186/s12885-024-13390-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-024-13390-4

Similar Items